Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript

NVO earnings call for the period ending December 31, 2023.

Related Keywords

Denmark ,United States ,Kalundborg ,Sjæand ,France ,Japan ,China ,Hillerod ,Hovedstaden ,Danish ,Karsten Munk Knudsen ,Doug Langa ,America Merrill Lynch ,Simon Baker Redburn ,Inversago Pharma ,Richard Parkes ,Seamus Fernandez ,Lilly Zepbound ,Harry Sephton ,Pete Verdult Citi ,Richard Parkes Exane ,Sachin Jain ,Mark Purcell Morgan Stanley ,Michael Novod ,Martin Parkhoi ,Daniel Muusmann Bohsen ,Lars Fruergaard Jorgensen ,Simon Baker ,Mark Purcell ,Pete Verdult ,Michael Novod Nordea ,Paribas Exane ,Louise Chen ,Mike Nedelcovych ,Richard Vosser Jpmorgan ,Martin Holst Lange ,Redburn Atlantic ,Peter Verdult ,Camilla Sylvest ,Daniel Bohsen ,Louise Chen Cantor Fitzgerald ,Richard Vosser ,Seamus Fernandez Guggenheim ,Head Of Development ,Corporate Affairs ,Nordea ,Sachin Jain Bank ,Barclays ,Citigroup ,Morgan Stanley ,Company Analyst ,Novo Nordisk ,North America ,Karsten Munk ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Vice President ,Commercial Strategy ,Western Ontario ,Mcmaster Universities Osteoarthritis Index ,Kansas City ,Chief Financial ,Forma Therapeutics ,Enskilda Banken ,Emily Field ,Cantor Fitzgerald ,Skandinaviska Enskilda Banken ,Guggenheim Partners ,Redburn Partners ,Executive Vice President ,Chief Executive Officer ,